Telo Genomics Corp Stock Probability of Future OTC Stock Price Finishing Over 0.099

TDSGF Stock  USD 0.09  0  2.22%   
Telo Genomics' future price is the expected price of Telo Genomics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Telo Genomics Corp performance during a given time horizon utilizing its historical volatility. Check out Telo Genomics Backtesting, Telo Genomics Valuation, Telo Genomics Correlation, Telo Genomics Hype Analysis, Telo Genomics Volatility, Telo Genomics History as well as Telo Genomics Performance.
  
Please specify Telo Genomics' target price for which you would like Telo Genomics odds to be computed.

Telo Genomics Target Price Odds to finish over 0.099

The tendency of Telo OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 0.1  or more in 90 days
 0.09 90 days 0.1 
about 38.59
Based on a normal probability distribution, the odds of Telo Genomics to move over $ 0.1  or more in 90 days from now is about 38.59 (This Telo Genomics Corp probability density function shows the probability of Telo OTC Stock to fall within a particular range of prices over 90 days) . Probability of Telo Genomics Corp price to stay between its current price of $ 0.09  and $ 0.1  at the end of the 90-day period is about 17.06 .
Assuming the 90 days horizon Telo Genomics has a beta of 0.59. This usually implies as returns on the market go up, Telo Genomics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Telo Genomics Corp will be expected to be much smaller as well. Additionally Telo Genomics Corp has an alpha of 0.5809, implying that it can generate a 0.58 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Telo Genomics Price Density   
       Price  

Predictive Modules for Telo Genomics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Telo Genomics Corp. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.0913.82
Details
Intrinsic
Valuation
LowRealHigh
0.000.0813.81
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Telo Genomics. Your research has to be compared to or analyzed against Telo Genomics' peers to derive any actionable benefits. When done correctly, Telo Genomics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Telo Genomics Corp.

Telo Genomics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Telo Genomics is not an exception. The market had few large corrections towards the Telo Genomics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Telo Genomics Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Telo Genomics within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.58
β
Beta against Dow Jones0.59
σ
Overall volatility
0.02
Ir
Information ratio 0.04

Telo Genomics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Telo Genomics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Telo Genomics Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Telo Genomics Corp is way too risky over 90 days horizon
Telo Genomics Corp has some characteristics of a very speculative penny stock
Telo Genomics Corp appears to be risky and price may revert if volatility continues
Telo Genomics Corp has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (2.11 M) with profit before overhead, payroll, taxes, and interest of 0.
Telo Genomics Corp has accumulated about 2.69 M in cash with (1.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05.

Telo Genomics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Telo OTC Stock often depends not only on the future outlook of the current and potential Telo Genomics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Telo Genomics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding59.4 M
Shares Float53.6 M

Telo Genomics Technical Analysis

Telo Genomics' future price can be derived by breaking down and analyzing its technical indicators over time. Telo OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Telo Genomics Corp. In general, you should focus on analyzing Telo OTC Stock price patterns and their correlations with different microeconomic environments and drivers.

Telo Genomics Predictive Forecast Models

Telo Genomics' time-series forecasting models is one of many Telo Genomics' otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Telo Genomics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.

Things to note about Telo Genomics Corp

Checking the ongoing alerts about Telo Genomics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Telo Genomics Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Telo Genomics Corp is way too risky over 90 days horizon
Telo Genomics Corp has some characteristics of a very speculative penny stock
Telo Genomics Corp appears to be risky and price may revert if volatility continues
Telo Genomics Corp has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (2.11 M) with profit before overhead, payroll, taxes, and interest of 0.
Telo Genomics Corp has accumulated about 2.69 M in cash with (1.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05.

Other Information on Investing in Telo OTC Stock

Telo Genomics financial ratios help investors to determine whether Telo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Telo with respect to the benefits of owning Telo Genomics security.